← Back to Clinical Trials
Recruiting NCT06981624

Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Radial Artery Occlusion
Sponsor Olivier F. Bertrand
Study Type INTERVENTIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-13
Completion 2026-08
Interventions
No heparin

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.

Eligibility Criteria

Inclusion Criteria: * Any patient referred for a diagnostic transradial catheterism Exclusion Criteria: * Unable to understand study design or provide informed consent * Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine * Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access. * Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}